Dilated cardiomyopathy: An update

Veterinary Clinics of North America - Small Animal Practice

Volumn 34, Issue 5, 2004, Pages 1187-1207

  O'Grady, Michael R ^a   O'Sullivan, M Lynne ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALPHA TOCOPHEROL; AMIODARONE; AMRINONE; ANTIARRHYTHMIC AGENT; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARNITINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FISH OIL; FUROSEMIDE; MAGNESIUM; MILRINONE; PIMOBENDAN; PLACEBO; SOTALOL; SPIRONOLACTONE; TAURINE; UBIDECARENONE;

BREED; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; DOG; HEART TRANSPLANTATION; MORTALITY; NONHUMAN; PROGNOSIS; REVIEW;

ANIMALS; CARDIOMYOPATHY, DILATED; DOG DISEASES; DOGS; PEDIGREE;

CANIS FAMILIARIS;

EID: 4444349915     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2004.05.009     Document Type: Review

References (82)

1. Harpster N. Boxer cardiomyopathy In: Kirk R.W. editor. Current veterinary therapy 8th edition. 1983 329-337 WB Saunders Philadelphia
2. Meurs K.M. Canine dilated cardiomyopathy-recognition and clinical management. In: Proceedings of the 26th Annual Waltham Diets/OSU Symposium for the Treatment of Small Animal Diseases, Columbus, OH, 2002:13-18.
3. Wynne J. Braunwald E. The cardiomyopathies and myocarditides In: Braunwald E. Zipes D.P. Libby P. editors, Heart disease: a textbook of cardiovascular medicine 6th edition. 2001 1751-1806 WB Saunders Philadelphia
4. Sisson D.D. Thomas W.P. Keene B.W. Primary myocardial disease in the dog In: Ettinger S.J. Feldman E.C. editors, Textbook of veterinary internal medicine 5th edition. 2000 874-895 WB Saunders Philadelphia
5. Kittleson M.D. Primary myocardial disease leading to chronic myocardial failure (dilated cardiomyopathy and related diseases) In: Kittleson M.D. Kienle R.D. editors, Small animal cardiovascular medicine 1998 319-346 Mosby St. Louis
6. Tidholm A. Haggstrom J. Borgarelli M. Tarducci A. Canine idiopathic dilated cardiomyopathy. Part I: aetiology, clinical characteristics, epidemiology and pathology Vet J 162 2001 92-107
7. Cobb M.A. Odedra R. Latif N. Dunn M.J. Use of indirect immunofluorescence and Western blotting to assess the role of circulating antimyocardial antibodies in dogs with dilated cardiomyopathies Res Vet Sci 56 1994 245-251
8. Day M.J. Inheritance of serum auto-antibody, reduced IgA and autoimmune disease in a canine breeding colony Vet Immunol Immunopathol 53 1996 207-221
9. Braz-Ruivo L. An investigation for latent parvovirus DNA in the myocardium and serum antibodies against myosin and laminin in dogs with dilated cardiomyopathy [DVSc thesis] 1999 University of Guelph Guelph
10. O'Grady M.R. Horne R. The prevalence of dilated cardiomyopathy in Doberman pinschers: a 4.5 year follow-up [abstract] J Vet Intern Med 12 1998-199
11. Calvert C.A. Meurs K.M. CVT update: Doberman Pinscher occult cardiomyopathy In: Bonagura J.D. Kirk R.W. editors, Kirk's current veterinary therapy 8th edition. 2000 756-760 WB Saunders Philadelphia
12. Calvert C.A. Hall G. Jacobs G. Pickus C. Clinical and pathologic findings in Doberman pinschers with occult cardiomyopathy that died suddenly or developed congestive heart failure: 54 cases (1984-1991) J Am Vet Med Assoc 210 210 1997 505-511
13. Calvert C.A. Jacobs G.J. Bradycardia resulting in syncope during exercise in Doberman pinscher dogs with cardiomyopathy [abstract] J Vet Intern Med 9 1995 202
14. O'Grady M.R. Horne R. Outcome of 103 asymptomatic Doberman pinschers: incidence of dilated cardiomyopathy in a longitudinal study [abstract] J Vet Intern Med 9 1995 199
15. O'Grady M.R. Horne R. Gordon S.G. Does angiotensin converting enzyme inhibitor therapy delay the onset of congestive heart failure or sudden death in Doberman pinschers with occult dilated cardiomyopathy [abstract]? J Vet Intern Med 11 1997 138
16. Calvert C.A. Jacobs G.J. Smith D.D. Rathbun S.L. Pickus C.W. Association between results of ambulatory electrocardiography and development of cardiomyopathy during long-term follow-up of Doberman pinschers J Am Vet Med Assoc 216 2000 34-39
17. O'Grady M.R. Echocardiographic evaluation of the normal Doberman pinscher [abstract] J Vet Intern Med 4 1990 116
18. Harpster N.K. Cardiac arrhythmias in the Irish Wolfhound: preliminary study. In: Proceedings of the 12th Annual American College of Veterinary Internal Medicine Forum, San Francisco, CA, 1994. p. 17-22.
19. Vollmar A.C. The prevalence of cardiomyopathy in the Irish Wolfhound: a clinical study of 500 dogs J Am Anim Hosp Assoc 36 2000 125-132
20. O'Sullivan M.L. Echocardiographic assessment of diastolic function and neurohormonal activation in Doberman Pinschers with dilated cardiomyopathy [DVSc thesis] 2003 University of Guelph Guelph
21. Giannuzzi P. Temporelli P.L. Bosimini E. Silva A. Imparato A. Corra U. et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction J Am Coll Cardiol 28 1996 383-390
22. Monnet E. Orton E.C. Salman M. Boon J. Idiopathic dilated cardiomyopathy in dogs: survival and prognostic indicators J Vet Intern Med 9 1995 12-17
23. Tidholm A. Svensson H. Sylven C. Survival and prognostic factors in 189 dogs with dilated cardiomyopathy J Am Anim Hosp Assoc 33 1997 364-368
24. Ettinger S.J. Benitz A.M. Ericsson G.F. Cifelli S. Jernigan A.D. Longhofer S.L. et al. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group J Am Vet Med Assoc 213 1998 1573-1577
25. BENCH Study Group. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial J Vet Cardiol 1 1999 7-18
26. Sisson D. O'Grady M.R. Calvert C.A. Myocardial diseases of dogs Fox P.R. Sisson D. Moise N.S. (Eds.). Textbook of canine and feline cardiology: principles and clinical practice 2nd edition. 1999 581-619 WB Saunders Philadelphia
27. Tidholm A. Jonsson L. Dilated cardiomyopathy in the Newfoundland: a study of 37 cases J Am Anim Hosp Assoc 1983-1994 32 1996 465-470
28. Calvert C.A. Dilated congestive cardiomyopathy in Doberman pinschers Compend Contin Educ Pract Vet 8 1986 417-430
29. Tidholm A. Jonsson L. A retrospective study of dilated cardiomyopathy (189 cases) J Am Anim Hosp Assoc 33 1997 544-550
30. Bahler R.C. Assessment of prognosis in idiopathic dilated cardiomyopathy Chest 121 2002 1016-1019
31. Saxon L.A. Stevenson W.G. Middlekauff H.R. Fonarow G. Woo M. Moser D. et al. Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 72 1993 62-65
32. Fruhwald F.M. Dusleag J. Eber B. Fruhwald S. Zweiker R. Klein W. Long-term outcome and prognostic factors in dilated cardiomyopathy. Preliminary results Angiology 45 1994 763-770
33. Hofmann T. Meinertz T. Kasper W. Geibel A. Zehender M. Hohnloser S. et al. Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants Am Heart J 116 1988 1455-1463
34. Cohn J.N. Levine T.B. Olivari M.T. Garberg V. Lura D. Francis G.S. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819-823
35. Parameshwar J. Keegan J. Sparrow J. Sutton G.C. Poole-Wilson P.A. Predictors of prognosis in severe chronic heart failure Am Heart J 123 1992 421-426
36. Cheng V. Kazanagra R. Garcia A. Lenert L. Krishnaswamy P. Gardetto N. et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386-391
37. Isnard R. Pousset F. Trochu J. Chafirovskaia O. Carayon A. Golmard J. et al. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure Am J Cardiol 86 2000 417-421
38. Pacher R. Stanek B. Hulsmann M. Koller-Strametz J. Berger R. Schuller M. et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure J Am Coll Cardiol 27 1996 633-641
39. Stanek B. Frey B. Hulsmann M. Koller-Strametz J. Hartter E. Schuller M. et al. Validation of big endothelin plasma levels compared with established neurohumoral markers in patients with severe chronic heart failure Transplant Proc 29 1997 595-596
40. Anguita M. Arizon J.M. Bueno G. Latre J.M. Sancho M. Torres F. et al. Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy Am J Cardiol 72 1993 413-417
41. Rihal C.S. Nishimura R.A. Hatle L.K. Bailey K.R. Tajik A.J. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis Circulation 90 1994 2772-2779
42. Hung J. Koelling T. Semigran M.J. Dec G.W. Levine R.A. Di Salvo T.G. Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy [abstract] Am J Cardiol 82 1998 1301-1303 A10
43. Koelling T.M. Aaronson K.D. Cody R.J. Bach D.S. Armstrong W.F. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction Am Heart J 144 2002 524-529
44. Xie G.Y. Berk M.R. Smith M.D. Gurley J.C. DeMaria A.N. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure J Am Coll Cardiol 24 1994 132-139
45. Dini F.L. Dell'Anna R. Micheli A. Michelassi C. Rovai D. Impact of blunted pulmonary venous flow on the outcome of patients with left ventricular systolic dysfunction secondary to either ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 85 2000 1455-1460
46. Dini F.L. Michelassi C. Micheli G. Rovai D. Prognostic value of pulmonary venous flow Doppler signal in left ventricular dysfunction: contribution of the difference in duration of pulmonary venous and mitral flow at atrial contraction J Am Coll Cardiol 36 2000 1295-1302
47. Calvert C.A. Pickus C.W. Jacobs G.J. Brown J. Signalment, survival, and prognostic factors in Doberman pinschers with end-stage cardiomyopathy J Vet Intern Med 11 1997 323-326
48. Dries D.L. Exner D.V. Gersh B.J. Domanski M.J. Waclawiw M.A. Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials J Am Coll Cardiol 32 1998 695-703
49. Liu S.K. Tilley L.P. Animal models of primary myocardial diseases Yale J Biol Med 53 1980 191-211
50. Calvert C.A. Diagnosis and management of ventricular tachyarrhythmias in Doberman pinschers with cardiomyopathy In: Bonagura J.D. editor, Kirk's current veterinary therapy 12th edition. 1995 799-806 WB Saunders Philadelphia
51. Borgarelli M, Tarducci A, Santilli R.A, Chiavegato D, D'Agnolo G, Mannelli A, et al. Echo prognostic indicators for DCM. In: Proceedings of the 18th Annual American College of Veterinary Internal Medicine Forum, Seattle, WA, 2000. p. 78-79.
52. Fioretti M. Delli Carri E. Epidemiological survey of dilatative cardiomyopathy in dogs [abstract] Veterinaria 2 1988 81
53. Borgarelli M. Tarducci A. Tidholm A. Haggstrom J. Canine idiopathic dilated cardiomyopathy. Part II: pathophysiology and therapy Vet J 162 2001 182-195
54. Ware W.A. Keene B.W. Outpatient management of chronic heart failure In: Bonagura J.D. editor, Kirk's current veterinary therapy 13th edition. 2000 748-752 WB Saunders Philadelphia
55. Sisson D.D. Medical management of refractory congestive heart failure in dogs Bonagura J.D. editor, Kirk's current veterinary therapy 13th edition. 2000 752-756 WB Saunders Philadelphia
56. McDonagh T.A. Robb S.D. Murdoch D.R. Morton J.J. Ford I. Morrison C.E. et al. Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9-13
57. Oyama M.A. Blood-based detection of occult heart disease. In: Proceedings of the 21st Annual American College of Veterinary Internal Medicine Forum, Charlotte, NC, 2003.
58. Oyama M.A. Solter P.F. Prosek R. Ostapkowicz R.R. Sisson D.D. Cardiac troponin-I levels in dogs and cats with cardiac disease [abstract] J Vet Intern Med 17 3 2003 400
59. Mishiro Y. Oki T. Yamada H. Wakatsuki T. Ito S. Evaluation of left ventricular contraction abnormalities in patients with dilated cardiomyopathy with the use of pulsed tissue Doppler imaging J Am Soc Echocardiogr 12 1999 913-920
60. Chetboul V. Escriou C. Blot S. Tessier D. Pouchelon J.L. Litzler P.Y. et al. Early detection of myocardial dysfunction in a dog model of dilated cardiomyopathy by tissue Doppler imaging [abstract] Circulation 104 Suppl 2 2001 II351
61. Strickland K.N. Doppler tissue imaging in Doberman Pinschers. In: Proceedings of the 21st Annual American College of Veterinary Internal Medicine Forum, Charlotte, NC, 2003.
62. O'Sullivan M.L. O'Grady M.R. Minors S.L. The ability of selected plasma neurohormones and diastolic echo parameters to characterize normal Dobermans and Dobermans with dilated cardiomyopathy [abstract] J Vet Intern Med 17 3 2003 398
63. Klewer S.E. Goldberg S.J. Donnerstein R.L. Berg R.A. Hutter J.J. Jr. Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer J Am Coll Cardiol 19 1992 394-401
64. Minors S.L. O'Grady M.R. Resting and dobutamine stress echocardiographic factors associated with the development of occult dilated cardiomyopathy in healthy Doberman pinscher dogs J Vet Intern Med 12 1998 369-380
65. Ajiki K. Murakawa Y. Yanagisawa-Miwa A. Usui M. Yamashita T. Oikawa N. et al. Autonomic nervous system activity in idiopathic dilated cardiomyopathy and in hypertrophic cardiomyopathy Am J Cardiol 71 1993 1316-1320
66. Minors S.L. O'Grady M.R. Heart rate variability in the dog: is it too variable? Can J Vet Res 61 1997 134-144
67. Kittleson M.D. Management of heart failure In: Kittleson M.D. Kienle R.D. editors, Small animal cardiovascular medicine 1998 149-194 Mosby St. Louis
68. Meurs K.M. Spier A.W. Wright N.A. Atkins C.E. DeFrancesco T.C. Gordon S.G. et al. Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers J Am Vet Med Assoc 221 2002 522-527
69. COVE Study Group. Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group J Vet Intern Med 9 1995 243-252
70. IMPROVE Study Group. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study J Vet Intern Med 9 1995 234-242
71. Fox P.R. The effect of drug therapy on clinical characteristics and outcome in dogs with heart failure. In: Proceedings of the 10th Annual American College of Veterinary Internal Medicine Forum, San Diego, CA, 1992. p. 592-593.
72. Ettinger S.J, Benitz A.M, Ericsson G.F. Relationship of enalapril with other CHF treatment modalities. In: Proceedings of the 12th Annual American College of Veterinary Internal Medicine Forum, San Francisco, CA, 1994. p. 251-253.
73. Hassenfuss G. Holubarsch C. Heiss H.W. Allgeier M. Just H. Effects of pimobendan on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy: comparison with nitroprusside J Cardiovasc Pharmacol 14 Suppl 1989 S31-S35
74. Goto Y. Hata K. Mechanoenergetic effect of pimobendan in failing dog hearts Heart Vessels 12 Suppl 1997 103-105
75. Fuentes V.L. Corcoran B. French A. Schober K.E. Kleemann R. Justus C. A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy J Vet Intern Med 16 2002 255-261
76. Lombard C.W. Clinical experience with pimobendan. In: Proceedings of the British Veterinary Cardiology Society Meeting, 2000.
77. O'Grady M.R. Minors S.L. O'Sullivan M.L. Horne R. Evaluation of the efficacy of pimobendan to reduce mortality and morbidity in Doberman pinschers with congestive heart failure due to dilated cardiomyopathy [abstract] J Vet Intern Med 17 3 2003 440
78. Oyama M.A. Use of carvedilol in dogs with cardiomyopathy. In: Proceedings of the 20th Annual American College of Veterinary Internal Medicine Forum, Dallas, TX, 2002. p. 79.
79. Pitt B. Zannad F. Remme W.J. Cody R. Castaigne A. Perez A. et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709-717
80. Freeman L.E. Nutritional therapy of heart disease. In: Proceedings of the 26th Annual Waltham Diets/OSU Symposium for the Treatment of Small Animal Diseases, Columbus, OH, 2002. p. 53-56.
81. Abraham W.T. Hayes D.L. Cardiac resynchronization therapy for heart failure Circulation 103 2003 2596-2603
82. Gordon S.G. An acute evaluation of dual-chamber pacing for the treatment of Doberman Pinschers with dilated cardiomyopathy [DVSc thesis] 1998 University of Guelph Guelph